Latest Insider Transactions at National Health Investors Inc (NHI)
This section provides a real-time view of insider transactions for National Health Investors Inc (NHI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATIONAL HEALTH INVESTORS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATIONAL HEALTH INVESTORS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 31
2024
|
Robert A Mccabe Jr Director |
BUY
Open market or private purchase
|
Direct |
437
+1.98%
|
$28,405
$65.83 P/Share
|
May 06
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-1.26%
|
$14,720
$64.72 P/Share
|
Feb 27
2024
|
Charlotte A Swafford Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+8.32%
|
$580,000
$58.69 P/Share
|
Feb 23
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+30.0%
|
-
|
Feb 23
2024
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.1%
|
-
|
Feb 23
2024
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+6.99%
|
-
|
Feb 23
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+5.49%
|
-
|
Feb 23
2024
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+5.24%
|
-
|
Oct 01
2023
|
Robert G Adams Director |
SELL
Acquisition or disposition by will or laws
|
Indirect |
85,411
-100.0%
|
-
|
Aug 30
2023
|
James R Jobe Director |
BUY
Open market or private purchase
|
Direct |
1,000
+6.26%
|
$51,000
$51.4 P/Share
|
May 05
2023
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+9.78%
|
-
|
May 05
2023
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+20.75%
|
-
|
May 05
2023
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+7.6%
|
-
|
May 05
2023
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.89%
|
-
|
May 05
2023
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+50.0%
|
-
|
Dec 14
2022
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.55%
|
$56,000
$56.6 P/Share
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,065
-32.81%
|
$1,076,355
$67.1 P/Share
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+27.24%
|
$971,649
$53.41 P/Share
|
Aug 15
2022
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+1.73%
|
$97,500
$65.93 P/Share
|
Dec 30
2021
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.16%
|
$114,000
$57.25 P/Share
|
Dec 01
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+2.35%
|
$102,000
$51.6 P/Share
|
Nov 29
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+2.44%
|
$52,000
$52.86 P/Share
|
Sep 30
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+4.88%
|
$106,000
$53.86 P/Share
|
Sep 29
2021
|
D. Eric Mendelsohn CEO and President |
BUY
Open market or private purchase
|
Direct |
2,000
+1.07%
|
$108,000
$54.39 P/Share
|
Sep 17
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+3.9%
|
$85,500
$57.25 P/Share
|
Sep 16
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.05%
|
$85,500
$57.5 P/Share
|
Sep 14
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.23%
|
$87,000
$58.0 P/Share
|
Sep 10
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.41%
|
$87,000
$58.5 P/Share
|
Sep 09
2021
|
Robert A Mccabe Jr Director |
BUY
Open market or private purchase
|
Direct |
468
+2.61%
|
$27,612
$59.84 P/Share
|
Jul 06
2021
|
W Andrew Adams Director |
SELL
Bona fide gift
|
Indirect |
45,307
-20.38%
|
-
|
Jun 17
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,184
+3.68%
|
$76,960
$65.0 P/Share
|
Feb 22
2021
|
W Andrew Adams Director |
SELL
Payment of exercise price or tax liability
|
Direct |
17,344
-47.5%
|
$1,196,736
$69.79 P/Share
|
Feb 22
2021
|
W Andrew Adams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+35.39%
|
$1,200,000
$60.52 P/Share
|
Dec 14
2020
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.18%
|
$134,000
$67.75 P/Share
|
Nov 18
2020
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
4,000
+4.55%
|
$264,000
$66.33 P/Share
|
Nov 17
2020
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+1.24%
|
$66,000
$66.45 P/Share
|